VIMTA LABS
|
The Current P/S Ratio of VIMTA LABS is 8.72.
Share Price | ₹658.7 | Aug 22,2025 |
Market Cap | ₹2,931.2 Cr | |
Sales-TTM | ₹336.1 Cr | TTM-Consolidated Results |
Price/Sales | 8.72x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of VIMTA LABS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹2,931.2 Cr] as on Aug 22,2025
(/) Sales [ ₹336.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 8.72x ]
Thus, for VIMTA LABS , the investors are currently willing to pay '8.72 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of VIMTA LABS !
The chart below summarizes the trend in P/S Ratio of VIMTA LABS over the last five years.
Historical PS (Price/Sales) ratio chart of VIMTA LABS
PS Ratio Performance Analysis for VIMTA LABS
- VIMTA LABS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.04x.
- VIMTA LABS 's operated at median p/e ratio of 2.19x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VIMTA LABS 's p/e ratio peaked in Mar2024 at 3.1x.
- VIMTA LABS 's p/e ratio hit its five-year low in Mar2020 of 0.72x.
How does VIMTA LABS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
VIMTA LABS | 336.1 | 8.72 | 2,931.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.33 | 394,187.0 |
DIVIS LABORATORIES LTD | 9,652.0 | 16.92 | 163,282.0 |
CIPLA LTD | 27,811.2 | 4.62 | 128,619.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.54 | 124,712.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.18 | 106,577.0 |
MANKIND PHARMA LTD | 12,956.2 | 8.30 | 107,559.0 |
ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.21 | 99,496.4 |
LUPIN LTD | 23,375.9 | 3.86 | 90,234.1 |
AUROBINDO PHARMA LTD | 32,024.8 | 1.90 | 60,998.7 |
ABBOTT INDIA LTD | 6,589.9 | 10.29 | 67,806.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs VIMTA LABS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.90x |
Max industry PS | 16.92x |
Median industry PS | 7.33x |
Average industry PS | 7.26x |
You may also like the below Video Courses